Cite

HARVARD Citation

    Noujaim, J. et al. (2016). P.(L576P) -KIT mutation in GIST: Favorable prognosis and sensitive to imatinib?. Cancer biology & therapy. 17 (5), pp. 543-545. [Online]. 
  
Back to record